Search - tctmd.com

Displaying 1 - 20 of 336

Sort: Relevancy | Date

News Conference News TCT 2016

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

L.A. McKeown

November 07, 2016

News Industry News TCT 2016

Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

November 02, 2016

News Industry News TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

November 02, 2016

News Conference News TCT 2016

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Yael L. Maxwell

November 02, 2016

Presentation TCT 2016

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

Presenter: Eustaquio Maria Onorato, Richard Smalling, Robert J. Sommer

November 01, 2016

Presentation TCT 2016

The REDUCE Trial: Will It Be Positive and What Will We Learn?

Presenter: Eustaquio Maria Onorato, Richard Smalling, John F. Rhodes

November 01, 2016

Presentation TCT 2016

What Should Be the Next Series of Clinical Trials in PFO Closure?

Presenter: Eustaquio Maria Onorato, Richard Smalling, John D. Carroll

November 01, 2016

Presentation TCT 2016

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Presenter: Eustaquio Maria Onorato, Richard Smalling, David E. Thaler

November 01, 2016

Presentation TCT 2016

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Presenter: Eustaquio Maria Onorato, Richard Smalling

November 01, 2016

Presentation TCT 2016

Building a Successful PFO Closure Program

Presenter: John D. Carroll, Christian Spies

November 01, 2016

Presentation TCT 2016

Available Devices/Techniques for Closure of PFO

Presenter: John D. Carroll, Christian Spies, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

The RoPE Score: How to select pathologic PFO?

Presenter: John D. Carroll, Christian Spies, David E. Thaler

November 01, 2016

Presentation TCT 2016

What Do the Randomized Clinical Trials Tell Us and How Did the FDA Respond?

Presenter: John D. Carroll, Christian Spies

November 01, 2016

Presentation TCT 2016

Impact of Percutaneous Mitral Valve Repair and Replacement on RHD Patient Outcomes

Presenter: Habib Gamra, Ahmed Suliman, Hugh J. Linnehan

November 01, 2016

Presentation TCT 2016

Long-term Outcomes of Coarctation Stenting

Presenter: John D. Carroll, Thomas J Forbes

November 01, 2016

Presentation TCT 2016

Delivery System and Therapeutic Challenges with RHD in Africa

Presenter: Habib Gamra, Ahmed Suliman, Mohamed Ahmed Sobhy

November 01, 2016

Presentation TCT 2016

Balloon Angioplasty Vs Bare Metal Vs Stents Covered Stents: How Do You Make the Decision?

Presenter: John D. Carroll, Thomas J Forbes, Elchanan Bruckheimer

November 01, 2016

Presentation TCT 2016

Update on Epidemiology, Prevention, Screening, and Control

Presenter: Habib Gamra, Ahmed Suliman, Bernard J. Gersh

November 01, 2016

Presentation TCT 2016

Technical Steps in Coarctation Stenting: Step-by-Step

Presenter: John D. Carroll, Thomas J Forbes, Eric Horlick

November 01, 2016

Presentation TCT 2016

Pulmonary Artery Angioplasty for Chronic Pulmonary Thromboembolic Disease: An Option for No Option Patients?

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud

November 01, 2016

Advertisement

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

The REDUCE Trial: Will It Be Positive and What Will We Learn?

What Should Be the Next Series of Clinical Trials in PFO Closure?

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Building a Successful PFO Closure Program

Available Devices/Techniques for Closure of PFO

The RoPE Score: How to select pathologic PFO?

What Do the Randomized Clinical Trials Tell Us and How Did the FDA Respond?

Impact of Percutaneous Mitral Valve Repair and Replacement on RHD Patient Outcomes

Long-term Outcomes of Coarctation Stenting

Delivery System and Therapeutic Challenges with RHD in Africa

Balloon Angioplasty Vs Bare Metal Vs Stents Covered Stents: How Do You Make the Decision?

Update on Epidemiology, Prevention, Screening, and Control

Technical Steps in Coarctation Stenting: Step-by-Step

Pulmonary Artery Angioplasty for Chronic Pulmonary Thromboembolic Disease: An Option for No Option Patients?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content